This summary was created by AI, based on 1 opinions in the last 12 months.
Experts have mixed opinions on the stock with some believing that the valuation is low and it could be a good time for investors while others think there are better options available. The consensus is unclear and the stock may be volatile. Overall, there is uncertainty regarding the potential of this stock for investors.
Metlife is a American stock, trading under the symbol MET-N on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET-N
In the last year, 2 stock analysts published opinions about MET-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by on . Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Metlife In the last year. It is a trending stock that is worth watching.
On 2024-03-27, Metlife (MET-N) stock closed at a price of $73.92.
Does not own shares. Financial services and insurance. Valuation is low and could be good time for investors. Does not own shares. Fundamentally a 6/10. Could be volatile. Better options out there for investors.